The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Notice of Results

24 Aug 2010 07:00

RNS Number : 4984R
Surgical Innovations Group PLC
24 August 2010
 



For immediate release

24 August 2010

 

Surgical Innovations Group plc

("SI" or "the Group")

Notice of Results

 

Surgical Innovations Group plc (AIM:SUN), the designer and manufacturer of innovative medical devices, advises that it will be announcing its Interim Results for the six months ended 30 June 2010 on Tuesday, 14 September 2010.

- Ends -

 

Enquiries:

Surgical Innovations Group plc

Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597

graham.bowland@surginno.co.uk

www.surginno.com

 

Westhouse Securities Limited

Tim Feather / Matthew Johnson

Tel: +44 (0) 113 246 2610

tim.feather@westhousesecurities.com

www.westhousesecurities.com

 

Media enquiries:The Communications Portfolio

Ariane Comstiveariane.comstive@communications-portfolio.co.uk

Tel: +44 (0) 20 7536 2028

Mob: +44 (0) 7785 922 354

Notes to Editors:

About Surgical Innovations Group plc

 

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group's main focus is on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen.

 

Surgical Innovations has pioneered Resposable® instrumentation combining both single use and reusable components ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio. 

 

Through an established network of 45 distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia. The Group's strategy is to sell its own branded instruments as well as to provide large medical device companies on an OEM basis including Teleflex Medical, Gyrus, Olympus and CareFusion.

 

The Group's products include:

 YelloPort+plus®

A resposable® laparoscopic port access system that combines both single-use and reusable components

Logi®Range

resposable® laparoscopic instrumentation that combines both single-use and reusable components

Quick®Range

single-use instruments, with an ergonomic handle to ensure accurate control of the instrument. The range includes scissors, graspers and dissectors

The Group employs over 100 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards. 

 For more information, see www.surginno.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORDMGZRKFMGGZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.